跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rotundine
首页
药物
Rotundine
Rotundine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
APPLICATION OF FLAVONOID C-GLYCOSIDE MONOMER COMPOUND
WO 2020043182 A1
申请人: SHANGHAI INST BIOLOGICAL SCIENCES CAS
优先权: 2018
CN
WO
4 件公开
Medicinal composition containing rotundine for anayesia and giving up drug-taking
CN 1483407 A
申请人: INST OF TOXICANT AND MADICINE
优先权: 2002
CN
Sustained releasing capsule of rotundine and its preparation method
CN 1704058 A
申请人: HANGZHOU MINSHENG PHARM GROUP
优先权: 2004
CN
Orally disintegrating tablet of rotundine and its preparation method
CN 1704059 A
申请人: HANGZHOU MINSHENG PHARM GROUP
优先权: 2004
CN
Dispersant rotundine tablet and its prepn process
CN 1706383 A
申请人: HANGZHOU MINSHENG PHARM GROUP
优先权: 2004
CN
Slow release tablet of rotundine and production process
CN 1726914 B
申请人: INST PHARM & TOXICOLOGY AMMS
优先权: 2004
CN
Rotundine orally disintegrating tablet and its preparing process
CN 1634056 A
申请人: WANG LIQIANG
优先权: 2004
CN
Luotongding oral cavity disintegration tablet and preparation thereof
CN 1778300 B
申请人: LUYE NATURAL DRUG RES DEV CO LTD SHANDONG
优先权: 2004
CN
Rotundine orally disintegrating tablets and preparation method thereof
CN 102451165 A
申请人: QUANTUM HIGH TECH BEIJING RES INST CO LTD
优先权: 2010
CN
Process technique to prepare rotundine based on different plants
CN 103145703 A
申请人: LI YUSHAN
优先权: 2013
CN
第 1 / 4 页
上一页
下一页
药物
反馈